ORR:客观反应率
“客观缓解率”(Objective Response Rate,缩写为ORR)是临床试验中评价抗癌药物疗效的重要指标,通常指肿瘤缩小或消失的患者比例。这一术语在医药监管领域,尤其是美国食品药品监督管理局(FDA)的相关文件中被广泛使用,采用缩写“ORR”便于快速记录和交流。
Objective Response Rate具体释义
Objective Response Rate的英文发音
例句
- Secondary endpoints included objective response rate, one-year survival rate, overall survival, PFS assessment by chemotherapy type and safety.
- 二级终点包含了目标反应率,一年生存期,总生存率,化疗类型和安全性PFS评估。
- Primary endpoint was objective response rate ( ORR ) per mRECIST in the lead-in stage.
- 主要的研究终点是每个可评价病灶在诱导期治疗获得的客观有效率(ORR)。
- The primary end point was progression-free survival; secondary end points included the objective response rate, overall survival, and safety.
- 主要研究终点为无进展生存(PFS),次级研究终点包括客观有效率、总生存和安全性。
- Results : The objective response rate of neoadjuvant chemotherapy assessable in 21 patients was 43 %.
- 结果21例患者中新辅助性化疗的客观应答率达43%。
- The primary endpoint was objective response rate ( ORR ), and the second endpoints were the durative time of remission ( DTR ), time of tumor progression ( TTP ), time of treatment failure ( TTF ), safety assessment and adverse events.
- 主要终点指标是客观肿瘤缓解率(ORR),次要终点指标是肿瘤缓解持续时间(DTR)、肿瘤进展时间(TTP)、肿瘤治疗失败时间(TTF)、安全性评估和毒副反应。
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若ORR词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。